Drug intelligence / Profile preview

Gongliuxiao Capsules

Development stage: Unknown
Lead developer: 山东步长神州制药
Administration: Oral

Overview

Gongliuxiao Capsules is a Traditional Chinese Medicine (TCM) product developed by Shanxi Buchang Pharmaceutical for the treatment of uterine fibroids (leiomyomas). Formulated as an oral capsule, it contains a blend of herbal ingredients including *Prunella vulgaris*, *Sparganium stoloniferum*, *Curcuma zedoaria*, and *Concha Ostreae*. The medicine is designed to "soften hardness and dissipate nodules" while "activating blood and resolving stasis." Clinically, it is used to reduce the volume of uterine fibroids and alleviate associated symptoms such as menstrual irregularities and pelvic pain. It is approved in China.

Brand names: Gongliuxiao Capsules
Other names: Gongliuxiao Jiaonang

Targets

PR (Progesterone receptor)

Beyond the preview

Go deeper on Gongliuxiao Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gongliuxiao Capsules.

Explore the full profile